Related Experiment Video
Updated: Mar 26, 2026
23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
19.7K
An Innovative Method to Enhance the Modified DOTS for TB Patients
Hassan Yekrang Sis1, Jalil Rashedi2, Fariba Azabdaftari3
1Department of Healthcare Administration, Tabriz University of Medical Sciences, Tabriz, Iran.
Tanaffos
|February 10, 2016
Summary
Professional-family mix directly observed treatment, short-course (PFM-DOTS) significantly improved tuberculosis patient knowledge and adherence compared to family-based DOTS. PFM-DOTS is recommended for better tuberculosis care and treatment outcomes.
Area of Science:
- Public Health
- Infectious Diseases
- Patient Education
Background:
- Effective patient communication and education are crucial for managing chronic diseases like tuberculosis at home.
- Enhancing patient knowledge about disease and treatment processes improves overall care.
- Home-based care principles are vital for successful patient management.
Purpose of the Study:
- To compare the effectiveness of two Directly Observed Treatment, Short-Course (DOTS) strategies in managing pulmonary tuberculosis.
- To evaluate the impact of professional-family mix DOTS (PFM-DOTS) versus family-based DOTS (FB-DOTS) on patient knowledge and treatment adherence.
Main Methods:
- A semi-experimental study involving 57 pulmonary tuberculosis patients.
- Two groups were compared: PFM-DOTS and FB-DOTS.
- Knowledge assessment of patients and family supervisors before and after intervention.
Main Results:
- The PFM-DOTS group showed a significantly greater increase in knowledge compared to the FB-DOTS group (P<0.001).
- Treatment adherence was higher in the PFM-DOTS group (100%) than in the FB-DOTS group (86.8%) (P<0.001).
Conclusions:
- PFM-DOTS implementation is a more effective method for the correct care and treatment of tuberculosis patients.
- This approach aligns with World Health Organization (WHO) recommendations for combating tuberculosis.
- Enhanced patient and family knowledge positively impacts treatment adherence and outcomes.
More Related Videos
Related Concept Videos
01:28Pulmonary Tuberculosis V
761
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
761
01:26Pulmonary Tuberculosis IV
628
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
628
01:29Therapeutic Drug Monitoring: Affecting Factors
324
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
324
01:29Pulmonary Tuberculosis I
1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
01:28Pulmonary Tuberculosis II
2.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.0K
01:16Therapeutic Drug Monitoring: Overview and Classification
508
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
508